<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Nichols, Emma Hitt</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">De Ruysscher, Dirk</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Accelerated Sequential Radiotherapy and Survival in NSCLC</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-06-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">15-17</style></pages><abstract><style  face="normal" font="default" size="100%">Shorter overall treatment time with radiotherapy (RT) appears to improve outcomes in patients with non—small cell lung cancer (NSCLC) compared with longer overall treatment time. This article outlines optimal RT dose and fractionation for concurrent and sequential schedules for stage III NSCLC.</style></abstract><number><style face="normal" font="default" size="100%">3</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>